Selling your veterinary practice in Indiana in 2026 clears 5-7x EBITDA at the single-DVM lifestyle tier, 7-9.5x at 2-3 DVM general practice scale, 9.5-11.5x at the $1M-$3M EBITDA 4-8 DVM PE platform sweet spot (clean books to 12x), and 11-13x at $3M+ multi-doctor specialty scale. Indianapolis and Fort Wayne metro density support platform-quality deals. Active IN buyers include Mars Veterinary Health, NVA/Ethos, Mission Pet Health, VetCor, PetVet Care Centers, Heartland, plus MedVet for doctor-controlled CPVM exits.

Quick Answer
Indiana veterinary practices and animal hospitals sell for 5-7x EBITDA at the single-DVM lifestyle tier (below the PE diligence floor), 7-9.5x EBITDA at 2-3 DVM general practice scale, 9.5-11.5x EBITDA at the $1M-$3M EBITDA 4-8 DVM PE platform sweet spot (clean books to 12x), and 11-13x EBITDA at $3M+ EBITDA multi-doctor / specialty / referral scale (16-18x for marquee specialty hospitals). Multi-site groups command 12-15x platform-of-platform pricing. PE buyers contributed roughly 80% of total 2024 vet deal capital, with cumulative PE investment of $51.6B (2017-2023) + $9.3B (Jan-Apr 2024 alone). Active acquirers include Mars Veterinary Health (VCA, Banfield, BluePearl, strategic permanent capital), NVA / Ethos (JAB Holding), Mission Pet Health (Shore Capital, ~750+ clinics post-Mission+SVP merger July 2025), VetCor (Oak Hill + Harvest + Cressey), PetVet Care Centers (KKR), Heartland (Gryphon majority recap 2024-25), AmeriVet (AEA + ADIA), VPP (Audax), Innovetive Petcare (Metalmark), UVC (Nordic Capital), Suveto (Levine Leichtman), Veritas (Percheron), Encore Vet (North Castle), Pieper (Chicago Pacific Founders), Rarebreed (Revelstoke), Bond Vet (Warburg Pincus, urgent care), VetEvolve (Varsity Healthcare), Thrive (TSG Consumer), plus MedVet (95% DVM-owned + Leonard Green minority) and Galaxy Vets (ESOP) for doctor-controlled exits.
Christoph Totter · Managing Partner, CT Acquisitions
Lower middle market M&A across professional services, home services, commercial services, and IT · Updated June 2026
Indiana is a two-speed veterinary M&A market, and which half you sit in decides how hard buyers compete for you. The northwest corner of the state sits inside Chicago commuting range, so a Hammond, Gary or Valparaiso practice draws bids from Chicago-headquartered consolidators that treat it as a metro bolt-on. Indianapolis is a self-contained large metro of roughly 2.17 million people (US Census Bureau 2025 estimate) with its own in-market specialty and emergency demand. The rest, from Fort Wayne down through the rural southern counties, is reached opportunistically from a distant hub rather than fought over by a local cluster. Private-equity capital has poured into the sector, with cumulative US veterinary investment of $51.6 billion across 2017 to 2023 plus $9.3 billion in January through April 2024 alone (American Economic Liberties Project), and PE buyers supplied roughly 80% of 2024 deal capital, so the money is there, it is the geography that sets your bargaining position.
This guide is built for the Indiana owner who wants the number and the mechanism. It covers 2026 multiples by EBITDA tier read against a bifurcated Indiana bidder pool, the wellness-plan premium that moves a general practice most, the named platforms acquiring here with current ownership detail, Purdue role as the in-state DVM pipeline, and the parts of an Indiana deal that differ from the national template: Indiana status as a corporate-practice-restricted state, which forces a friendly professional corporation plus a management services organization rather than direct corporate ownership, the Indiana professional corporation statute that requires an Indiana-licensed veterinarian shareholder, the fact that Indiana recent physician non-compete bans do not reach veterinarians so associate covenants stay enforceable, and the Indiana tax picture, a flat state rate stacked with a county local income tax that varies by where your practice sits. CT Acquisitions works the buy side only. We are not a business broker, the acquirer covers our fee, and an owner pays no commission, no retainer, and signs no exclusivity contract. If you want the wider picture first, the veterinary hub guide and the Private Equity in Veterinary 2026 report set the national backdrop, and the free valuation survey runs in about three minutes.
Price starts with adjusted EBITDA and a size band, the way it does nationally, but in Indiana how many buyers chase a given band depends on the map. A solo book in a southern county and a four-doctor hospital outside Indianapolis sit in different worlds even at the same earnings.
The starting point is adjusted EBITDA, sorted into size bands that look the same as anywhere in the country, but what differs in Indiana is how crowded each band gets. At the bottom, a solo lifestyle clinic or a rural mixed-animal book earning under $500K is simply too small for corporate diligence to pencil, so it usually moves doctor-to-doctor or to a small regional group somewhere in the 5x-to-7x range. Step up to a two or three-doctor general practice earning $500K to $1M and the number sits between 7x and 9.5x, with the upper half reserved for high-margin books that are not propped up by a single vet. The $1M-to-$3M hospital staffed by four to eight doctors is where the platforms press hardest; it clears 9.5x to 11.5x and touches 12x when the books are clean and there is a real bench behind the owner. Past $3M, which generally means a multi-doctor specialty or referral group, the range runs 11x to 13x and can reach 16x to 18x when an aggregator wants a standout specialty hospital to fill a gap on its map. Across all of it, specialty, emergency and 24/7 work carries a premium of roughly 1.5x to 3x over plain general practice. For outside markers: R.L. Hulett Q1 2025 Pet M&A Update logged closed deals from 6x to 16x adjusted EBITDA, the American Economic Liberties Project pegs private equity at about 80 percent of 2024 deal capital, and a wellness book covering more than 15 percent of eligible general-practice cases typically adds half a turn to a turn and a half on top of the band.
| Indiana practice profile | Typical multiple | What moves it in Indiana |
|---|---|---|
| Single-DVM lifestyle / rural mixed-animal under $500K EBITDA | 5-7x EBITDA | Below the platform diligence floor; sells DVM-to-DVM, common across the southern and far-rural counties |
| 2-3 DVM general practice ($500K-$1M EBITDA) | 7-9.5x EBITDA | Draws real bids near Indianapolis and especially in the Chicago-reach northwest, even at modest scale |
| 4-8 DVM hospital ($1M-$3M EBITDA) | 9.5-11.5x EBITDA (clean books to 12x) | The tier platforms compete for; the Purdue-fed associate bench and wellness penetration decide the top end |
| $3M+ EBITDA multi-doctor / specialty / referral | 11-13x EBITDA (16-18x for marquee specialty) | Indianapolis specialty and emergency demand plus referral catchment carry it |
| Multi-site groups (3+ hospitals) | 12-15x EBITDA | Regional density, especially a northwest-plus-Indianapolis footprint, commands platform-of-platform pricing |
What turns a floor number into a strong one is how many bidders show up, and in Indiana that count tracks drive time. Picture the same four-doctor hospital at $1.5M of EBITDA. Sold quietly to one buyer down in a southern county, it might land at 9.5x to 10.5x, call it $14M to $16M. Drop that identical hospital into Hammond or Merrillville, inside Chicago reach, and two or three Chicago-headquartered platforms come to the table; whichever one can absorb it as a bolt-on and re-mark it on its own balance sheet will stretch a turn or two higher to win the territory. That is the part no multiples grid can print: your address is itself a pricing input.
If an Indiana general-practice owner could change only one thing before selling, it would be the membership book. A funded wellness program rewrites one-off visits as predictable monthly income, and that is exactly the quality a buyer pays extra for.
Of all the moves available to an Indiana general-practice owner, building a membership book does the most for the multiple. The reason is cash-flow shape. Software vendors report plan uptake above 18 percent of eligible patients nationally, and members spend two to three times what drop-in clients do, so a strong program replaces lumpy transactional billing with a dependable monthly stream, which an acquirer underwrites at a richer price because it dampens seasonal swings, proves clients come back, and lets the buyer model lifetime value with confidence after close. Banfield showed it could be run at scale through its Optimum Wellness Plans, and the groups shopping Indiana, Blue River PetCare, Mission Pet Health, the Mars brands, generally want an acquired clinic migrated onto a branded plan inside a year to a year and a half. The way to be paid for it is to start early: launch roughly 18 to 24 months ahead of a sale, drive uptake past the 12-to-15-percent mark of eligible general-practice cases, carve the recurring revenue out as its own line, and have the quality-of-earnings analysis treat it as a separate book. Indiana sellers who arrive with penetration over 20 percent and members who have stayed longer than two years routinely pick up 75 to 150 basis points over the band, whereas a clinic that lives on one-off visits gets marked down under the same scrutiny.
What a buyer is really pricing is whether the doctors stay. Pet demand is not in question; clinical continuity is, so an Indiana offer pays most of the money up front and parks the rest against the people walking out the door.
Every term sheet an Indiana owner receives is, underneath the headline number, a bet on doctor continuity. That is why the money arrives in layers. On a two-to-eight-doctor hospital, expect something like 70 to 80 cents on the dollar in cash at close. Another 10 to 20 cents converts into equity, usually units in a Newco or in the platform holding company itself, and the final 5 to 15 cents waits as an earnout that pays out only if three things hold: the selling owner keeps billing clinical hours across the first one to three years, the associates stay on through the first year or two, and trailing EBITDA does not slide below where it started. Push enterprise value above $5M and the equity slice tends to climb to the 20-to-30-cent range. Where sellers lose money quietly is compensation math. An owner who has been paying associates 20 to 25 percent of production plus a year-end distribution will watch the buyer re-strike that at a flat 22 to 24 percent of production with the distribution gone, then rebuild adjusted EBITDA off the lower figure; settling a ProSal number with the acquirer half a year to a year ahead of signing is the only reliable defense. The retention hooks have real teeth. Fall below a 32-hour clinical week, or under four-fifths of your prior production for a rolling two-month stretch, and the earnout trips; lose an associate inside a year and a half and a chunk of escrow reverts to the buyer. One Indiana wrinkle worth naming: relief work booked through IndeVets, Roo and comparable services does not count against the production floor, and relief is simpler to source near Purdue and the Indianapolis area than in the rural south.
A platform does not pay you what your hospital earns; it pays you a slice of what those earnings become once they sit inside a group trading at a far higher multiple. That arbitrage is the whole game, and in Indiana it only opens when the buyer actually wants your patch.
Here is the mechanic that funds the entire roll-up. Your standalone four-doctor practice earning $1.5M might sell direct at 9.5x to 10.5x. Fold those same dollars into a group the market values at 15x to 18x, and on the acquirer books they are suddenly worth five to seven turns more than you were paid, which is precisely why the likes of Blue River PetCare, Mission Pet Health and VetCor will reach up to 11x or 12x for a $1M-to-$2M Indiana hospital they have a reason to own. The qualifier is everything: that reason has to exist. If your county, your caseload or your earnings quality is off a buyer thesis, you get the floor regardless of how many platforms are technically out there. This is where Indiana geography pays off. An owner in the Chicago-reach northwest can put several Chicago-based platforms in competition and has a real shot at finding the one for whom the practice fits, turning that fit into an extra turn or two, while an owner in a county no platform is building out does not get that pull. Debt tightened through 2024 and 2025 and shaved a turn or two off platform pricing versus the 2021-2022 top, but the late-2025 rate cuts have put committed financing back on the table, which is a large part of why Indiana buyers are moving again in 2026.
Every national acquirer technically buys in Indiana, but the ones that matter for your deal are the ones that can actually reach your county. Chicago-based groups dominate the northwest, the national strategics are everywhere, and a doctor-owned lane exists for sellers who will not hand a fund the clinic.
Who really competes for an Indiana practice depends less on the full acquirer list than on reach. Mars Veterinary Health is the giant, holding VCA, Banfield and the BluePearl emergency and specialty network as permanent strategic capital rather than a fund, and its density across Chicagoland extends into the northwest counties. Two Chicago-headquartered consolidators punch above their weight in this state: Blue River PetCare, backed by Partners Group and running about 194 clinics that keep their own names and clinical independence, and GoodVets, backed by General Atlantic and SkyKnight, both able to add a northwest-Indiana location to an existing Chicago cluster with next to no new-market cost. On the national side, NVA belongs to JAB Holding Company alongside its Ethos emergency and specialty arm, and the 2022 FTC order from the SAGE deal still fences JAB specialty and ER purchases within 25 miles of an existing JAB clinic in California and Texas. Mission Pet Health, a Shore Capital Partners company, hit roughly 750 clinics once Mission Veterinary Partners and Southern Veterinary Partners merged in July 2025. VetCor, run by Oak Hill Capital with Harvest Partners and Cressey & Co., remains one of the busiest general-practice tuck-in buyers. On ownership, keep the cap tables current: PetVet Care Centers is KKR-held since 2022 (not Onex), Heartland Veterinary Partners went Gryphon Investors majority in its 2024-2025 recap (not American Securities), and AmeriVet has been AEA Investors and the Abu Dhabi Investment Authority since February 2022 (not Imperial Capital). Rounding out the field are Veterinary Practice Partners (Audax), Innovetive Petcare (Metalmark), United Veterinary Care (Nordic Capital, not Atlantic Street), Suveto (Levine Leichtman, not LongueVue), Veritas (Percheron), Encore Vet Group (North Castle), Rarebreed (Revelstoke), Bond Vet (Warburg Pincus, urgent care), VetEvolve (Varsity Healthcare) and Thrive Pet Healthcare (TSG Consumer). For an owner unwilling to sell clinical control to a sponsor, the doctor-led options are genuine: MedVet, roughly 95 percent owned by its doctors and staff with a Leonard Green minority, keeps a specialty and emergency footprint in the Indianapolis market, and Galaxy Vets is the first US consolidator structured as an employee stock ownership plan. One structural note applies to all of them: because Indiana bars non-vet ownership, every one of these buyers has to come in through a friendly-PC-plus-management-company arrangement rather than taking the clinic directly.
Not every Indiana practice is bought by the same buyer or at the same price. Where your case mix falls on the hierarchy, companion-animal general practice, referral specialty, emergency, or large-animal, decides both the multiple and who even shows up to bid.
Think of the buyer universe as several pools that barely overlap. Companion-animal general practice is the one the platforms were built to roll up, priced from about 5x at the small end to roughly 12x for a well-run mid-size hospital, and the buyers reward a steady associate roster, controlled real estate and a live wellness book. At the top of the scale sit the referral specialties, surgery, internal medicine, oncology, cardiology, neurology, dermatology, ophthalmology, which fetch 11x to 14x and as much as 16x to 18x when a single hospital carries several boarded specialists and a thick referral base; in Indiana that action is an Indianapolis story, where MedVet and the Mars-owned BluePearl brand chase the same referral flow. Round-the-clock emergency and urgent care lands near 11x to 13x, propped up by how hard overnight shifts are to staff and by the specialty work it feeds. Then there is the large-animal world, mixed, equine and food-animal, which is a different market entirely across rural central and southern Indiana: it trades closer to 5x to 8x because herd economics, road time and USDA APHIS oversight resist the platform playbook, and the realistic buyer is usually another production-animal DVM or a regional operator rather than a fund. Mobile and house-call outfits ask little capital but give a buyer no real-estate anchor and little to consolidate, so platform interest is thin. The prize archetype is the multi-hospital group, and in Indiana a group that stitches a northwest cluster to an Indianapolis presence is the one that commands 12x to 15x, because it hands a buyer both density and a built-in list of future tuck-ins.
Our national data on veterinary practice valuation multiples shows what buyers actually pay by tier.
What is your Indiana veterinary practice actually worth?
CT Acquisitions runs a confidential, buy-side process across the 15+ active PE-backed veterinary consolidators plus MedVet and Galaxy Vets for DVMs who want a doctor-controlled exit. No broker commission, no retainer, no exclusivity contract, the buyer pays our fee.
Indiana restricts corporate ownership of a veterinary practice, so buyers use a friendly professional corporation plus a management company rather than holding the clinic directly. Demand concentrates in Indianapolis and in the Chicago-reach northwest, and Purdue feeds the in-state doctor pipeline.
Indiana restricts non-veterinarian ownership of a practice, which is the first thing that separates it from permissive states. Under the Indiana professional corporation statute (Ind. Code 23-1.5-2-3 and 23-1.5-3-1) a professional corporation rendering veterinary services may issue shares only to persons authorized to render that service and must keep at least one Indiana-licensed veterinarian as a shareholder, and the Indiana Veterinary Medical Association confirms that a practice must be a vet sole proprietorship, a partnership with a licensed-vet partner, or such a professional corporation, not an ownerless or unrestricted LLC. The practical effect is that a corporate buyer cannot hold the clinical entity outright and instead runs a friendly-PC plus management-company arrangement. Demand concentrates where the people and the doctors are. Indianapolis, at roughly 2.17 million people (US Census Bureau 2025 metro estimate), is the deepest in-state market and carries the specialty and emergency demand, while northwest Indiana effectively borrows the Chicago buyer bench through short drive times. Purdue University College of Veterinary Medicine in West Lafayette is the only DVM school in the state, has run a steady class near 84 students historically, and sends graduates who tend to stay in Indiana (Purdue CVM); that in-state pipeline lowers the staffing risk buyers weigh most heavily, strongest along the Lafayette-to-Indianapolis corridor and across the north. Statewide population growth is modest and Indianapolis-concentrated, so buyers price the central corridor and the northwest more aggressively than the rural south.
Two Indiana specifics decide what you actually keep: which metro you sit in, which sets how many buyers fight for you, and the state plus county income tax that comes off the gain. Neither shows up on a national multiples chart, and both are worth modeling before you go to market.
Start with the metros, because in Indiana they are the pricing engine the national playbook ignores. The Indianapolis metro, the largest in the state, is where the specialty and emergency caseload lives and where a stand-alone four-doctor hospital draws in-market and national bidders without borrowing anyone else bench. Fort Wayne, the second metro, is a genuine but shallower market where one or two regional operators may circle a well-run practice rather than a crowd. Evansville, down in the southwest near the Kentucky line, plus the smaller Lafayette, Bloomington, South Bend and Terre Haute markets, each support a solid local practice but rarely a bidding war. And the northwest corner, Lake and Porter counties around Hammond, Gary, Merrillville and Valparaiso, is the outlier that behaves like Chicago rather than Indiana, because it is Chicago by drive time. The upshot is that two matched hospitals with matched earnings can fetch meaningfully different offers depending only on which of these zones they occupy, so the first question an Indiana owner should answer is not what is my multiple but how many buyers can reach me.
The Purdue pipeline is shifting in a way that matters for a buyer staffing math. The college has announced a roughly 50 percent expansion of its DVM class, moving from about 84 students toward roughly 120 (Purdue CVM), which over the next several years widens the in-state supply of associates an acquirer has to line up after the founder slows down. A buyer underwriting an Indiana hospital reads that as falling post-close staffing risk, particularly in the Lafayette-Indianapolis corridor the program feeds most directly, and it is a point a prepared seller should raise rather than wait for diligence to surface.
Then there is the tax the national template tends to get stale. Indiana levies one flat individual income tax rate, 2.95 percent in 2026, stepping down to 2.90 percent in 2027 under the HB 1001 phase-down (Tax Foundation; Indiana Department of Revenue), and it taxes a capital gain as ordinary income with no preferential rate. The piece that is easy to miss, and that older write-ups leave out, is the county layer: every one of Indiana 92 counties levies its own local income tax on top of the state rate, and those county rates run from roughly half a percent to nearly three percent (Indiana Department of Revenue). A seller who lives in a high-rate county therefore pays a noticeably larger combined rate on the gain than one a county over, so after-tax proceeds depend partly on where the owner resides, not only on the headline price. It is worth modeling with an Indiana tax advisor well before signing, because it can change the real take-home on two otherwise identical offers.
The northwest counties trade on Chicago deep bidder bench; Indianapolis stands on its own as a steady metro that reaches south toward Louisville and Cincinnati; the rural stretches see few platforms at all.
Sitting close to an existing platform is only the opening; it pays off only once you also clear the scale bar, and then three further things settle the intensity of the bidding: how deep the local metro is, whether doctors are easy to hire, and which way demand is trending. Below is where Indiana lands on each of the five.
| Factor | What it means for your exit |
|---|---|
| Buyers near you | Northwest Indiana (Hammond/Gary/Valparaiso) is ~30-60 min from downtown Chicago, so a NW-IN practice sits inside the deep Chicago platform bench (Blue River and GoodVets are both Chicago-HQ’d); Indianapolis is a stable stand-alone metro (MedVet in-metro, Mars/VCA national reach) whose own 2-hour circle catches Louisville and Cincinnati but NOT Chicago (3-3.5hr); rural Indiana is platform-thin. |
| Your size gate | Sliding scale by zone: NW-IN’s Chicago proximity LOWERS the bar (even a solid solo clears as a Chicagoland bolt-on); Indianapolis is MODERATE; rural Indiana is HIGHER (a distant-hub buyer needs more scale and quality to justify a standalone unit). No flat EBITDA figure asserted, expressed as single-DVM vs multi-DVM by zone. |
| Metro depth | NW-IN effectively borrows Chicago’s x-large bench (deep multi-bidder tension); Indianapolis (~1.9M, large) is a real but shallower in-metro bidder set widened modestly by 2-hour reach to Cincinnati (2.27M) and Louisville; rural Indiana is thin one-buyer territory. |
| DVM labor supply | Purdue (West Lafayette, ~1hr from Indy) is a top-15 national DVM school AND the #1 vet-tech program, a genuine statewide pipeline that lowers a buyer’s staffing risk, strongest in the Lafayette-Indianapolis corridor and northern Indiana; the standard rural-recruiting headwind persists in far-southern/deep-rural counties. |
| Demand trend | Steady, Indy-concentrated growth (+0.56% statewide 2025, fastest among neighbors but slowing; Indy metro ~62% of projected state growth) on a resilient insurance/logistics/pharma (Eli Lilly $13B) base, durable, dependable demand rather than a high-appreciation tailwind; middle-income spend, not premium-coastal. |
Owners in the northwest, around Hammond, Gary, Munster and Valparaiso, sit a half-hour to an hour from the Chicago city center, which plants them inside one of the richest metro platform benches anywhere. Blue River PetCare and GoodVets both run out of Chicago, the Mars brands and VCA blanket the suburbs, and any of them can fold a northwest practice into a cluster it already operates with barely any new-market cost. That is real bargaining power at the table, and it is the best seller footing in the state. Move to Indianapolis and the picture is a solid self-standing metro: MedVet keeps a specialty and emergency hospital in town, the national strategics carry local footprint, and a two-hour drive reaches Louisville and Cincinnati, though never Chicago, so the bench is real but thinner than up north. Out in the rural and small-metro counties, a buyer reaches you when it suits its map rather than fighting a nearby rival for the deal.
Scale is the gate on all of that, and the height of the gate changes with how far you are from a hub. Up in the northwest it sits low: a Chicago platform can swallow even a healthy single-doctor clinic as a bolt-on, so most tidy practices get through. Around Indianapolis it is middling. In the rural counties it climbs, because a buyer out there has to stand your clinic up as its own supported site and underwrite the hiring, so a sub-scale rural practice more often ends up with a local or regional buyer than a national one. No single dollar cutoff carries across the zones, so read it in relative terms: a clean multi-doctor book travels well everywhere, while a solo practice does best where a nearby hub can prop it up.
Staffing is the one tailwind that is unmistakably Indiana own. Purdue fields a top-15 DVM program and the nation leading vet-tech program about an hour from Indianapolis, and its graduates lean toward staying in state, which answers the question that worries a buyer most, who runs the clinic once the founder eases off, and the effect is strongest down the Lafayette-Indianapolis corridor and across the northern counties. Demand, by contrast, is a gentle plus rather than a surge: Indiana outpaced each of its neighbors in 2025 yet remains a moderate-growth, middle-income Midwestern market resting on insurance, logistics and a fast-growing Eli Lilly, so buyers bank on dependable wellness-plan demand here instead of rapid price appreciation.
Two structural facts frame the deal itself. The first is ownership: Indiana does not let a non-veterinarian own the clinical entity, so a platform cannot simply buy your practice outright and instead routes the purchase through a management company paired with a friendly professional corporation, which adds legal steps without having kept the platforms away. The second is often misread: Indiana recent crackdown on non-competes is written for licensed physicians and does not reach veterinarians, so your associate doctors fall under ordinary common-law reasonableness, which means a sensibly drawn associate non-compete does hold up here. Factor in Indiana flat individual income tax, 2.95% in 2026 and set to drop to 2.90% in 2027 under the HB 1001 phase-down (Tax Foundation; Indiana Department of Revenue), plus the county-level income tax that every one of the 92 counties adds on top and the fact that the state taxes a gain as ordinary income, and Indiana reads as a comparatively buyer-friendly place to keep doctors after close. The takeaway: the northwest is the standout, a Chicago-bench market with a low scale gate; Indianapolis is a dependable multi-bidder metro; and the rural counties are a scarcity play that rewards a differentiated, well-run practice and punishes a sub-scale one, with Purdue pipeline lifting the whole map.
Selling an Indiana practice touches three regulatory layers, and the first is the one the national template gets right for Indiana: the state restricts non-veterinarian ownership, so the deal runs through a friendly-PC plus management-company structure. The layers are ownership structure, the practice license and DEA registration, and the antitrust backdrop.
Selling an Indiana veterinary practice touches three regulatory layers, and the first is the load-bearing one. Indiana restricts non-veterinarian ownership of a practice. Under the Indiana professional corporation statute (Ind. Code 23-1.5-2-3 on formation and 23-1.5-3-1 on who may hold shares), a professional corporation rendering veterinary services may issue shares only to persons authorized to render the professional service and must have at least one Indiana-licensed veterinarian shareholder, and the Indiana Veterinary Medical Association guidance is explicit that a sole proprietor must be a veterinarian, a partnership needs a veterinarian partner, and veterinarians are not among the professions permitted to use an unrestricted LLC. A private-equity or corporate buyer therefore cannot own the clinical entity outright. The standard answer is a friendly-PC plus management-services-organization structure: a licensed Indiana veterinarian owns the professional corporation that holds the license and employs the doctors, while the buyer owns a separate management company that holds the non-clinical assets and provides administration under a management services agreement, with a stock-transfer-restriction agreement keeping the PC friendly. That structure typically adds $50K to $150K of legal cost over a direct purchase. The second layer is licensing and controlled substances: the practice license runs under Ind. Code 25-38.1-3-1 through the Indiana Board of Veterinary Medicine at the Indiana Professional Licensing Agency, and separately each location that stores or dispenses controlled substances needs its own DEA registration, the new owner obtains a fresh DEA number, the controlled-substance inventory transfers with a documented count signed by both sides at close, and Schedule II drugs move on DEA Form 222. The third layer is antitrust posture: the 2020 NVA / Compassion-First and 2022 JAB / SAGE FTC consent orders remain in force, the May 2024 FTC and DOJ request for information named veterinary roll-ups as a concern, and a January 2025 FTC settlement signaled that stealth sub-HSR acquisitions in fragmented healthcare verticals are on the agenda, so a deal where the likely Indiana buyer already owns nearby specialty or emergency capacity can draw a longer review.
For an Indiana seller the sequence has one extra step a permissive state would not. First, structure: because Indiana restricts non-vet ownership, plan the friendly-PC plus management-company arrangement early with counsel who knows Ind. Code 23-1.5, and budget the extra legal cost and a short timing buffer for it. Second, the license: keep the practice license current through the Indiana Board of Veterinary Medicine and confirm the ownership and controlling-entity records are updated as part of closing. Third, DEA: the new owner secures a fresh DEA registration, the controlled-substance inventory transfers with a signed count, and Schedule II items move on Form 222. Fourth, antitrust: if the most likely bidder already holds specialty or emergency capacity near you, especially in the Indianapolis or Chicago-adjacent northwest clusters, build extra review time into the calendar. Plan on roughly 90 to 150 days from signing to close, with the friendly-PC structuring, the DEA reissuance and, in specialty-dense pockets, any FTC look as the constraints that set the pace.
Most of the closing machinery on an Indiana sale is standard veterinary deal-making, but two pieces bend to state law: the clinic cannot be transferred straight to the buyer, and associate non-competes hold up here even though physician ones are being curtailed.
Strip away the state-specific items and an Indiana sale looks like any other veterinary deal. On transactions above $5M of enterprise value, 20 to 30 percent of the proceeds usually roll into equity in a Newco or the platform holding company, vest across three to five years, and cash out at the next recapitalization on a four-to-six-year clock. A retention earnout parks 5 to 15 percent of consideration against the seller keeping up clinical hours, the associates staying through year one or two, and EBITDA holding, with the money clawed back if the seller slips under a 32-hour week or under four-fifths of prior production over any 60-day run. And the compensation recut appears here as everywhere: associates get reset to 22 to 24 percent of straight production and EBITDA is rebuilt on that basis, a 5-to-15-percent trim unless the seller gets ahead of it. Now the two Indiana bends. The first is the transfer itself. State law bars non-vet ownership, so the buyer never takes the clinical entity; the parties instead erect the friendly-PC-plus-management-company structure under Ind. Code 23-1.5, with an Indiana-licensed veterinarian holding the professional corporation and the buyer holding the management company, which adds paperwork and a little calendar to closing. The second bend favors the buyer. Indiana recent crackdown on non-competes is written for licensed physicians and does not extend to veterinarians, so associate-DVM covenants are judged by ordinary common-law reasonableness, and a restriction kept to a sensible time and radius that guards a real business interest will stand; the non-compete a departing owner signs as part of the sale is stronger still and almost always holds. As is typical, the building is often spun into its own entity at signing and leased back on a 15-to-20-year triple-net, leaving the real estate as separate optionality priced around 5.5 to 7.5 percent cap rates.
The thing pushing Indiana practices onto the market is not a shortage of young vets, it is a generation of owners reaching the end of their careers at once. Supply studies say the graduates are coming; the owners stepping back are the real story.
It is tempting to read the selling wave as a labor crisis, but the numbers point elsewhere. The 2025 AVMA Report on the Economic State of the Veterinary Profession puts the US workforce at about 130,415 DVMs, overwhelmingly in small-animal work, and the AAVMC 2024 supply-and-demand study expects existing colleges to cover aggregate demand into the mid-2030s, with the genuine gaps sitting in rural, food-animal and emergency coverage rather than everywhere. The force that actually moves transactions is age. JAVMA survey work across 2024 and 2025 reported that 31 percent of clinical-practice veterinarians mean to leave clinical work altogether within five years and 61 percent plan to dial their hours back, while about one in twelve practicing vets has already passed 66. Indiana sits on both ends of that at the same time. Near West Lafayette and Indianapolis the Purdue pipeline keeps associates in reasonable supply, better than in states with no in-state school, yet the owners who opened their doors in the 1980s and 1990s are now aging into retirement, and the shortfall is sharpest in the southern and rural counties. Pair that with financing that reopened after the late-2025 rate cuts and with Chicago-based and national platforms already able to reach the northwest and the capital, and the stretch from 2026 to 2030 becomes the moment the largest cohort of Indiana owners yet crosses 60.
A generalist advisor who treats an Indiana veterinary practice as any other services business will miss the levers that move the price and will misread the Indiana rules, most importantly the friendly-PC structuring the state ownership restriction requires.
A generalist advisor who treats an Indiana veterinary practice as any other services business will miss the levers that move the price and will misread the local rules. The wellness-plan documentation, the rollover-equity slice that monetizes at the next recap, the 5 to 15% production-comp recut buyers apply to pre-close numbers, the 32-hour and 80%-production earnout thresholds, and the split between enforceable sale-of-business non-competes and associate covenants are all veterinary-specific diligence items. Two of them are Indiana-specific. The first is that Indiana restricts non-veterinarian ownership, so the deal must be built as a friendly-PC plus management-company structure under Ind. Code 23-1.5 with an Indiana-licensed veterinarian holding the professional corporation, and an advisor who misses that either stalls the deal or structures it wrong. The second is that Indiana recent physician non-compete limits do not reach veterinarians, so associate covenants remain enforceable under common-law reasonableness, which changes how you draft them and how you value doctor retention. An Indiana seller working with someone who knows the current platform cap tables, which buyers can actually reach their county, and how Indiana licenses and structures a veterinary deal negotiates as an equal rather than being educated by the buyer diligence team at their own expense.
Owners who land at the top of their band did not stumble into it; they spent a year or two getting ready. Over 12 to 24 months the work falls into a handful of priorities, from the membership book to lining up the friendly-PC structure before closing week.
The sellers who reach the upper end of their band generally gave themselves a runway. If you have 12 to 24 months, these are the moves that pay:
For the broader framework, see our Private Equity in Veterinary 2026 report, our 36-month veterinary exit playbook, and the lower middle market buyer mandate report.
The money Indiana sellers leave on the table tends to come from the same handful of errors: pricing off revenue, ignoring the pay recut, pitching the wrong sponsors, treating a direct clinic sale as possible, and grabbing the first offer when the map supports an auction.
Companion guides for Indiana sellers:
Few healthcare-adjacent sectors consolidate as hard as veterinary, and Indiana is a solid if geography-dependent place to sell into that. The capital is proven, $51.6 billion of private-equity investment from 2017 through 2023 and $9.3 billion more in early 2024 per the American Economic Liberties Project, with 15-plus national platforms working alongside Mars permanent capital, and the supply of sellers keeps growing as the JAVMA 2024-2025 surveys show 61 percent of clinical veterinarians planning to cut hours inside five years. A four-to-eight-doctor Indiana hospital that shows up with membership penetration above 12 to 15 percent, a pay structure already normalized, a clean license and DEA record, the building carved out as optionality, a friendly-PC structure mapped in advance, and enforceable associate covenants can genuinely push to the top of its 9.5x-to-11.5x band, and a multi-site group can reach 12x to 15x. What drains value, over and over, is the same list: an un-handled compensation recut, outreach to sponsors who sold years ago, learning about the friendly-PC requirement too late, waving off the antitrust review in specialty-heavy metros, and accepting the first offer rather than turning your drive-time map into a real auction.
This guide reflects 2026 veterinary M&A conditions and CT Acquisitions direct work with active acquirers. Multiples are directional, not a guarantee; every practice is underwritten on its own doctor roster, wellness-plan penetration, adjusted EBITDA, real-estate optionality and growth profile. Indiana professional corporation and ownership rules under Ind. Code 23-1.5-2-3 and 23-1.5-3-1, the practice license under Ind. Code 25-38.1-3-1 and Indiana Board of Veterinary Medicine requirements, friendly-PC plus management-company structuring, DEA registration transfer, Indiana non-compete common-law standards and the scope of the state physician non-compete statutes, the 2022 FTC JAB / SAGE consent order, the May 2024 FTC / DOJ serial-acquisitions RFI, and Indiana state and county tax provisions all move over time, so check the current rules with qualified Indiana veterinary counsel before you rely on any of them in a deal.
If you operate a different business in Indiana, our state-specific sub-guides walk through the named PE buyers, current valuation multiples, and Indiana-specific deal mechanics for each vertical. You can also explore veterinary practice sales in other high-activity states.
It depends almost entirely on your size band and the quality of your earnings. A solo lifestyle clinic or rural mixed-animal book under $500K of EBITDA usually moves at 5x to 7x, below the point where a platform runs diligence, so it tends to sell to another doctor or a small regional group. A two or three-doctor general practice at $500K to $1M sits around 7x to 9.5x. The $1M-to-$3M hospital with four to eight doctors is the platform target band at 9.5x to 11.5x, reaching 12x on clean books. Above $3M, a multi-doctor specialty or referral group runs 11x to 13x, and a standout specialty hospital can see 16x to 18x; multi-site groups command 12x to 15x. R.L. Hulett Q1 2025 Pet M&A Update logged closed deals from 6x to 16x adjusted EBITDA. The biggest single lever you control is a membership book above 15 percent of eligible general-practice cases, which typically adds 75 to 150 basis points over the band.
All 15-plus active PE-backed national platforms plus Mars Veterinary Health acquire nationwide, but in Indiana the Chicago-based groups reach the northwest counties most readily. The most active buyers are Mars Veterinary Health (VCA, Banfield, BluePearl, permanent strategic capital rather than a fund), NVA and its Ethos division under JAB Holding Company (whose 2022 FTC order still limits specialty and ER deals within 25 miles of a JAB clinic in California and Texas), Mission Pet Health under Shore Capital Partners (about 750 clinics after the July 2025 Mission plus Southern Veterinary Partners merger), VetCor (Oak Hill Capital with Harvest Partners and Cressey & Co.), PetVet Care Centers (KKR since 2022, not Onex), Heartland Veterinary Partners (Gryphon Investors, not American Securities), and AmeriVet (AEA Investors and the Abu Dhabi Investment Authority, not Imperial Capital). Also in the field are Veterinary Practice Partners (Audax), Innovetive Petcare (Metalmark), United Veterinary Care (Nordic Capital), Suveto (Levine Leichtman), Veritas (Percheron), Encore Vet Group (North Castle), Pieper (Chicago Pacific Founders), Rarebreed (Revelstoke), Bond Vet (Warburg Pincus), VetEvolve (Varsity Healthcare) and Thrive (TSG Consumer), plus the Chicago-headquartered Blue River PetCare (Partners Group) and GoodVets (General Atlantic and SkyKnight). For a doctor-controlled exit, MedVet (mostly owned by its doctors and staff) and the ESOP-built Galaxy Vets are the alternatives. Because Indiana bars non-vet ownership, each buys through a friendly-PC plus MSO structure.
Yes. Indiana restricts non-veterinarian ownership of a veterinary practice, so this is the load-bearing structuring question for any Indiana sale. Under the Indiana professional corporation statute (Ind. Code 23-1.5-2-3 on formation and 23-1.5-3-1 on who may hold shares), a professional corporation rendering veterinary services may issue shares only to persons authorized to render the service and must keep at least one Indiana-licensed veterinarian as a shareholder, and the Indiana Veterinary Medical Association confirms a practice must be a veterinarian sole proprietorship, a partnership with a veterinarian partner, or such a professional corporation, not an unrestricted LLC. Because a corporate or private-equity buyer cannot own the clinical entity directly, Indiana deals run through a friendly-PC plus management-services-organization structure: a licensed Indiana veterinarian owns the professional corporation that holds the license and employs the doctors, while the buyer owns a separate MSO that provides administration and holds non-clinical assets under a long-term management services agreement, with a stock-transfer-restriction agreement keeping the PC friendly. That architecture typically adds $50K to $150K in transaction legal cost, but it has not kept platforms out of Indiana.
A funded membership program converts one-off visits into predictable monthly revenue, and that is the quality buyers pay a premium for. Industry uptake runs above 18 percent of eligible patients, members spend two to three times what drop-in clients do, and that recurring stream smooths seasonality and proves retention, so acquirers underwrite it at a higher multiple. You prove it from the practice-management data: trailing-24-month enrollment counts, retention by plan tier, the per-patient spend uplift versus non-members, and the contract base, all broken out as their own line and carried separately into the quality-of-earnings work. Indiana sellers who reach market above 20 percent penetration with members who have stayed past two years routinely clear 75 to 150 basis points over their size band, and sometimes a full turn or two.
The top Indiana numbers go to practices that have removed the risks a buyer fears. That means a four-to-eight-doctor bench so the practice does not hinge on one vet, membership penetration past 15 percent, an owner whose post-sale hours hold up (a 32-hour-plus week at 80 percent-plus of prior production), associate pay already normalized to 22 to 24 percent of straight production, low revenue concentration on any single doctor, a clean license and DEA history, an accurate Schedule II count, and enforceable non-competes for both owner and associates, which hold in Indiana because the physician restrictions do not reach veterinarians. Board-certified specialty hospitals (surgery, internal medicine, oncology, cardiology, neurology, dermatology, ophthalmology) and 24/7 emergency carry a 1.5x to 3x premium over general practice, and multi-site groups of three or more hospitals reach 12x to 15x for proven multi-location operating capability.
Figure on roughly 90 to 150 days from letter of intent to close, with preparation ahead of that. The prep stretch, typically four to eight weeks, covers membership documentation, pay normalization, a license and DEA review, and mapping the friendly-PC plus MSO structure with counsel who knows Ind. Code 23-1.5. Then expect about three to six weeks of confidential outreach to the active platforms plus MedVet and Galaxy Vets, three to five weeks to indications of interest and a signed letter, and the diligence-and-close run after that. The operational pacing items are the DEA reissuance and the friendly-PC structuring; in concentrated geographies, an FTC second request can add 60 to 180 days.
Nothing to you. CT Acquisitions works buy-side, not as a business broker, so the buyer pays our fee. There is no seller commission, no retainer, and no exclusivity contract.
Ready to talk about selling your Indiana veterinary practice?
Book a confidential 30-minute call. We will walk through your DVM roster, wellness-plan penetration, adjusted EBITDA and production-comp normalization, real estate optionality, premise permit and DEA transfer plan, and what your practice could realistically command from the active platform pool. No fee to you, the buyer pays our commission.
Book Your Free Call →